Antiviral Therapeutics Market, Global Outlook and Forecast 2022-2028

January 2022 | 68 pages | ID: AAFF03C31DB9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antiviral Therapeutics in Global, including the following market information:

Global Antiviral Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antiviral Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Herpes Antiviral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiviral Therapeutics include AbbVie Inc., GSK, Boehringer Ingelheim, Merck, Novartis, Beximco Pharmaceuticals, Pfizer, Roche and Bristol-Myers Squibb Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiviral Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiviral Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Herpes Antiviral Drugs
• Hepatitis Antiviral Drugs
• HIV Antiviral Drugs
• Influenza Antiviral Drugs
• Others

Global Antiviral Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmacies
• Others

Global Antiviral Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antiviral Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiviral Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antiviral Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie Inc.
• GSK
• Boehringer Ingelheim
• Merck
• Novartis
• Beximco Pharmaceuticals
• Pfizer
• Roche
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiviral Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiviral Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIVIRAL THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Antiviral Therapeutics Market Size: 2021 VS 2028
2.2 Global Antiviral Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antiviral Therapeutics Players in Global Market
3.2 Top Global Antiviral Therapeutics Companies Ranked by Revenue
3.3 Global Antiviral Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antiviral Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antiviral Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiviral Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Antiviral Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antiviral Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antiviral Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Herpes Antiviral Drugs
  4.1.3 Hepatitis Antiviral Drugs
  4.1.4 HIV Antiviral Drugs
  4.1.5 Influenza Antiviral Drugs
  4.1.6 Others
4.2 By Type - Global Antiviral Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Antiviral Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Antiviral Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Antiviral Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiviral Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Pharmacies
  5.1.6 Others
5.2 By Application - Global Antiviral Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Antiviral Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Antiviral Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Antiviral Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiviral Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Antiviral Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Antiviral Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Antiviral Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Antiviral Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antiviral Therapeutics Revenue, 2017-2028
  6.3.2 US Antiviral Therapeutics Market Size, 2017-2028
  6.3.3 Canada Antiviral Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Antiviral Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antiviral Therapeutics Revenue, 2017-2028
  6.4.2 Germany Antiviral Therapeutics Market Size, 2017-2028
  6.4.3 France Antiviral Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Antiviral Therapeutics Market Size, 2017-2028
  6.4.5 Italy Antiviral Therapeutics Market Size, 2017-2028
  6.4.6 Russia Antiviral Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Antiviral Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Antiviral Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antiviral Therapeutics Revenue, 2017-2028
  6.5.2 China Antiviral Therapeutics Market Size, 2017-2028
  6.5.3 Japan Antiviral Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Antiviral Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Antiviral Therapeutics Market Size, 2017-2028
  6.5.6 India Antiviral Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antiviral Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Antiviral Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Antiviral Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antiviral Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Antiviral Therapeutics Market Size, 2017-2028
  6.7.3 Israel Antiviral Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Antiviral Therapeutics Market Size, 2017-2028
  6.7.5 UAE Antiviral Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie Inc.
  7.1.1 AbbVie Inc. Corporate Summary
  7.1.2 AbbVie Inc. Business Overview
  7.1.3 AbbVie Inc. Antiviral Therapeutics Major Product Offerings
  7.1.4 AbbVie Inc. Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Inc. Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Antiviral Therapeutics Major Product Offerings
  7.2.4 GSK Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Antiviral Therapeutics Major Product Offerings
  7.3.4 Boehringer Ingelheim Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Antiviral Therapeutics Major Product Offerings
  7.4.4 Merck Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Antiviral Therapeutics Major Product Offerings
  7.5.4 Novartis Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Beximco Pharmaceuticals
  7.6.1 Beximco Pharmaceuticals Corporate Summary
  7.6.2 Beximco Pharmaceuticals Business Overview
  7.6.3 Beximco Pharmaceuticals Antiviral Therapeutics Major Product Offerings
  7.6.4 Beximco Pharmaceuticals Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Beximco Pharmaceuticals Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Antiviral Therapeutics Major Product Offerings
  7.7.4 Pfizer Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Roche
  7.8.1 Roche Corporate Summary
  7.8.2 Roche Business Overview
  7.8.3 Roche Antiviral Therapeutics Major Product Offerings
  7.8.4 Roche Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Roche Key News
7.9 Bristol-Myers Squibb Company
  7.9.1 Bristol-Myers Squibb Company Corporate Summary
  7.9.2 Bristol-Myers Squibb Company Business Overview
  7.9.3 Bristol-Myers Squibb Company Antiviral Therapeutics Major Product Offerings
  7.9.4 Bristol-Myers Squibb Company Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Company Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Antiviral Therapeutics Major Product Offerings
  7.10.4 Johnson & Johnson Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Antiviral Therapeutics Major Product Offerings
  7.11.4 Sanofi Antiviral Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antiviral Therapeutics Market Opportunities & Trends in Global Market
Table 2. Antiviral Therapeutics Market Drivers in Global Market
Table 3. Antiviral Therapeutics Market Restraints in Global Market
Table 4. Key Players of Antiviral Therapeutics in Global Market
Table 5. Top Antiviral Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antiviral Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antiviral Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antiviral Therapeutics Product Type
Table 9. List of Global Tier 1 Antiviral Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiviral Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antiviral Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antiviral Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antiviral Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antiviral Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antiviral Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antiviral Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antiviral Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antiviral Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antiviral Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antiviral Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antiviral Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antiviral Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antiviral Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antiviral Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antiviral Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antiviral Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antiviral Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antiviral Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. Antiviral Therapeutics Product Offerings
Table 32. AbbVie Inc. Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Antiviral Therapeutics Product Offerings
Table 35. GSK Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Antiviral Therapeutics Product Offerings
Table 38. Boehringer Ingelheim Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Antiviral Therapeutics Product Offerings
Table 41. Merck Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Antiviral Therapeutics Product Offerings
Table 44. Novartis Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Beximco Pharmaceuticals Corporate Summary
Table 46. Beximco Pharmaceuticals Antiviral Therapeutics Product Offerings
Table 47. Beximco Pharmaceuticals Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Antiviral Therapeutics Product Offerings
Table 50. Pfizer Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Antiviral Therapeutics Product Offerings
Table 53. Roche Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Company Corporate Summary
Table 55. Bristol-Myers Squibb Company Antiviral Therapeutics Product Offerings
Table 56. Bristol-Myers Squibb Company Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Antiviral Therapeutics Product Offerings
Table 59. Johnson & Johnson Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Antiviral Therapeutics Product Offerings
Table 62. Sanofi Antiviral Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antiviral Therapeutics Segment by Type in 2021
Figure 2. Antiviral Therapeutics Segment by Application in 2021
Figure 3. Global Antiviral Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiviral Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiviral Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiviral Therapeutics Revenue in 2021
Figure 8. By Type - Global Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antiviral Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antiviral Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inc. Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beximco Pharmaceuticals Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Company Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Antiviral Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)